Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


TRUST 2002 study shows levofloxacin resistance remains rare in S. pneumoniae


Correlations of antimicrobial resistance among s. pneumoniae in the U.S.: 2001-2002 trust surveillance

Resistance to commonly prescribed antibiotics is increasing among Streptococcus pneumoniae, a leading cause of respiratory illness. In the early 1990s, resistance to penicillin became a concern, however, in the last five years (1998-2002), S. pneumoniae has also exhibited increased resistance to other antibiotic classes, such as the macrolides (e.g. azithromycin, clarithromycin) and sulfonamides (e.g. trimethoprim-sulfamethoxazole). In the current U.S. study, the extent of resistance among S. pneumoniae was analyzed on both national and regional levels for the 2001-2002 respiratory season. The findings are presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego, on Sept. 29, 2002.

The findings are the result of the surveillance study, TRUST (Tracking Resistance in the U.S. Today) that was conducted by the Focus Technologies laboratory during the past respiratory season (TRUST 6, 2001-2002) to monitor changes in antibiotic resistance among S. pneumoniae. TRUST studies were initiated in 1996 to coincide with the release of levofloxacin into clinical use in the United States. The current study was the sixth consecutive study of respiratory pathogens conducted since the 1996-1997 respiratory season, and the current study consisted of 7,671 pneumococcal isolates collected from 238 clinical hospital laboratories geographically dispersed throughout 49 states. TRUST is the largest and most comprehensive annual surveillance program to monitor antimicrobial resistance among clinical isolates of S. pneumoniae in the United States.

Resistance to penicillin (18.4%) exceeded that reported in the previous 2000-2001 respiratory season (16.9%). Penicillin resistance data analyzed among the nine U.S. Bureau of the Census regions showed the highest prevalence in the West South Central (29.5%), East South Central (25.0%), and South Atlantic (23.3%) regions.

In the 2001-2002 TRUST study, resistance remained high for azithromycin (27.5%) and trimethoprim-sulfamethoxazole (26.0%), and remained very low for levofloxacin (0.9%). Analysis showed that azithromycin and trimethoprim-sulfamethoxazole minimal inhibitory concentrations (MICs) closely correlated with penicillin MICs , while levofloxacin MICs did not.

As observed in the previous three respiratory seasons, resistance to penicillin, azithromycin, and trimethoprim-sulfamethoxazole was commonly present in the same isolates of S. pneumoniae. Levofloxacin resistance remained rare (<1%) among the isolates collected during 2001-2002. The levofloxacin MIC90 value of 1 mg/ml and the MIC distributions for levofloxacin have not changed over the past four respiratory seasons.

Abby Harris | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Physicists made crystal lattice from polaritons

20.03.2018 | Physics and Astronomy

Mars' oceans formed early, possibly aided by massive volcanic eruptions

20.03.2018 | Physics and Astronomy

Thawing permafrost produces more methane than expected

20.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>